BioSpace News Archive

Lava Therapeutics B.V., a biotech company pioneering bispecific gamma-delta T cell engagers for cancer, today announced the appointment of Benjamin Winograd, M.D., Ph.D., as the company’s chief medical officer. Dr. Winograd is a seasoned drug development expert with significant experience leading oncology and hematology programs within the pharmaceutical industry. In this new role, Dr. Winograd

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, prior to market open.

Ovation Science Inc., announces an independent study has successfully proven the effectiveness of its DermSafe® hand sanitizer lotion against a human coronavirus, a surrogate for SARS-CoV-2.

Voltron Therapeutics, Inc. announced today it has initiated preclinical animal testing of the first construct of its HaloVax Self-Assembling Vaccine (SAV) against COVID-19. Voltron will take two different vaccines, with differing sets of targets into preclinical testing, in order to identify the best balance of immune responses for prevention of this pandemic pathogen. HaloVax is being developed in conjunction with Hoth Therapeutics, Inc. (NASDAQ

Dyadic Now Partnered with all of the Top Four Animal Health Companies Five Fully Funded Animal Health Research Projects with Three New Relationships Announced this Year

OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and commercializing novel oral liquid formulations, announced today that it has submitted for U.S. patent protection, for the first-ever powder for oral liquid formulation of duloxetine hydrochloride. Offering an important delivery alternative for a drug often used for major depressive and generalized anxiety di

Guardant Health, Inc. announced a strategic collaboration with Janssen Biotech, Inc. to pursue regulatory approval and commercialization of the Guardant360® CDx as a companion diagnostic for amivantamab, an investigational EGFR-MET bispecific antibody being studied in the treatment of non-small cell lung cancer.

Global Blood Therapeutics, Inc. announced that on July 1, 2020, the compensation committee of GBT’s board of directors granted 11 new employees restricted stock units for an aggregate of 27,550 shares of the company’s common stock.

Biotricity Inc. ( OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, today provided guidance on its financial results for the year ended March 31, 2020, announcing that it has experienced increases of approximately 260% in gross annual revenues, year over year, and 113% quarter over quarter. This guidance is being provided in advance of filing audited results within its 10-K, which it anticipates f

Dr. Howard Njoo, Canada’s Deputy Chief Public Health Officer, will hold a media technical briefing on data and modelling informing public health action on coronavirus disease.